Medical Oncology

, 31:268 | Cite as

The role of B7-H1 in gastric carcinoma: clinical significance and related mechanism

  • Dong Jiang
  • Yun-yun Xu
  • Fang Li
  • Biao Xu
  • Xue-guang Zhang
Original Paper


The aim of this study was to investigate the role of co-stimulatory molecule B7-H1 in gastric carcinoma, to assess its clinical significance, and to explore related mechanism. Expression of B7-H1 and interferon gamma (IFN-γ) was evaluated by immunohistochemistry in 205 gastric carcinoma tissues and nonmalignant para-carcinoma tissues and 30 normal tissues. Expression data were correlated with clinicopathologic features of the patients. Furthermore, gastric carcinoma cell line SGC7901, MGC803, and AGS were employed to assess the expression of B7-H1 under the stimulation of IFN-γ. There was no detectable or weak amount of B7-H1 in normal tissue, while 43 % (88/205) of gastric carcinoma tissues and nonmalignant para-carcinoma tissues were confirmed with B7-H1 positive (p < 0.01). High B7-H1 expression was significantly associated with the age (p < 0.01), alcohol (p < 0.05), carcinoma location (p < 0.01), and differentiation (p < 0.05). Moreover, IFN-γ and CD3+ T cells infiltration were found in carcinoma tissues, but not in normal tissues. In addition, the expression of B7-H1 was also found in gastric carcinoma cell lines (SGC7901, MGC803 and AGS), and IFN-γ could increase its expression. Our data suggest that B7-H1 may represent a new early diagnostic marker for patients with well-differentiated gastric carcinoma. Furthermore, given its immune-inhibitory function, B7-H1 may represent a potential target in the treatment of gastric carcinoma.


B7-H1 Gastric carcinoma Immunohistochemistry Gastric carcinoma cell line IFN-γ Diagnostic marker 



This work was supported by Projects of Soochow Science and Technology Plans SYS201325 and SYS201438.

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42(2):219–40. doi: 10.1016/j.gtc.2013.01.003.PubMedCrossRefGoogle Scholar
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107.PubMedCrossRefGoogle Scholar
  3. 3.
    Zou XN, Duan JJ, Huangfu XM, Chen WQ, Zhao P. Analysis of stomach cancer mortality in the national retrospective sampling survey of death causes in China, 2004–2005. Zhonghua Yu Fang Yi Xue Za Zhi. 2010;44(5):390–7.PubMedGoogle Scholar
  4. 4.
    Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, et al. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 2011;17(39):4421–8. doi: 10.3748/wjg.v17.i39.4421.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Immunol. 2003;21:807–39. doi: 10.1146/annurev.immunol.21.120601.141135.PubMedCrossRefGoogle Scholar
  6. 6.
    Flies DB, Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother. 2007;30(3):251–60. doi: 10.1097/CJI.0b013e31802e085a.PubMedCrossRefGoogle Scholar
  7. 7.
    Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002;2(2):116–26. doi: 10.1038/nri727.PubMedCrossRefGoogle Scholar
  8. 8.
    Vigano S, Perreau M, Pantaleo G, Harari A. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol. 2012;2012:485781. doi: 10.1155/2012/485781.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999;5(12):1365–9. doi: 10.1038/70932.PubMedCrossRefGoogle Scholar
  10. 10.
    Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res. 2004;10(15):5094–100. doi: 10.1158/1078-0432.CCR-04-0428.PubMedCrossRefGoogle Scholar
  11. 11.
    Xiao JX, Bai PS, Lai BC, Li L, Zhu J, Wang YL. B7 molecule mRNA expression in colorectal carcinoma. World J Gastroenterol. 2005;11(36):5655–8.PubMedGoogle Scholar
  12. 12.
    Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG, Xu N. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 2006;108(1):19–24. doi: 10.1016/j.acthis.2006.01.003.PubMedCrossRefGoogle Scholar
  13. 13.
    Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res. 2005;11(8):2947–53. doi: 10.1158/1078-0432.CCR-04-1469.PubMedCrossRefGoogle Scholar
  14. 14.
    Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006;66(7):3381–5. doi: 10.1158/0008-5472.CAN-05-4303.PubMedCrossRefGoogle Scholar
  15. 15.
    Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001;2(3):269–74. doi: 10.1038/85339.PubMedCrossRefGoogle Scholar
  16. 16.
    Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. 2006;8(3):190–8. doi: 10.1593/neo.05733.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45. doi: 10.1002/ijc.27711.PubMedCrossRefGoogle Scholar
  18. 18.
    Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B, et al. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer. 2006;119(2):317–27. doi: 10.1002/ijc.21775.PubMedCrossRefGoogle Scholar
  19. 19.
    Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol Immunother. 2007;56(8):1173–82. doi: 10.1007/s00262-006-0266-z.PubMedCrossRefGoogle Scholar
  20. 20.
    Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res. 2007;13(7):2151–7. doi: 10.1158/1078-0432.CCR-06-2746.PubMedCrossRefGoogle Scholar
  21. 21.
    Loos M, Giese NA, Kleeff J, Giese T, Gaida MM, Bergmann F, et al. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett. 2008;268(1):98–109. doi: 10.1016/j.canlet.2008.03.056.PubMedCrossRefGoogle Scholar
  22. 22.
    Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA. 2002;99(19):12293–7. doi: 10.1073/pnas.192461099.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793–800. doi: 10.1038/nm730.PubMedGoogle Scholar
  24. 24.
    Ye Y, Zhou L, Xie X, Jiang G, Xie H, Zheng S. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion. J Surg Oncol. 2009;100(6):500–4. doi: 10.1002/jso.21376.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Dong Jiang
    • 1
  • Yun-yun Xu
    • 3
  • Fang Li
    • 2
  • Biao Xu
    • 2
  • Xue-guang Zhang
    • 4
  1. 1.Department of Cardio-Thoracic SurgeryThe First Affiliated Hospital of Soochow UniversitySuzhouPeople’s Republic of China
  2. 2.Department of Human Anatomy, Histology and Embryology, School of Biology and Basic Medical SciencesSoochow UniversitySuzhouPeople’s Republic of China
  3. 3.Institute of PediatricsChildren’s Hospital Affiliated to Suzhou UniversitySuzhouPeople’s Republic of China
  4. 4.Institute of Clinical Immunology of Jiangsu ProvinceThe First Affiliated of Soochow UniversitySuzhouPeople’s Republic of China

Personalised recommendations